Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2

出版年份 2016 全文链接

标题

作者

关键词

celecoxib, chronic myelogenous leukemia (CML), cyclooxygenase-2 (COX2), AMP-activated kinase (AMPK), beta-catenin (β-catenin), mammalian target of rapamycin (mTOR)

出版物

Oncotarget

Volume 7, Issue 49, Pages -

出版商

Impact Journals, LLC

发表日期

2016-11-07

DOI

10.18632/oncotarget.13146

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started